Evidence map›Paper›PMID 39807246›Full record

SynthesisFrontiers in neurology2024

Outcomes following resective and disconnective strategies in the treatment of epileptic spasms: a systematic review of the literature and individual patient data meta-analysis.

Rachel Cottier, Farbod Niazi, Keshav Goël, Catherine Korman, Tiphaine Porte, Thierry Ducruet, Giulia Cossu, Christina Briscoe, Avantika Singh, Chellamani Harini and 4 more

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Rachel CottierBrain and Development Research Axis, Azrieli CHU Ste-Justine Research Center, Montreal, QC, Canada.
Farbod NiaziBrain and Development Research Axis, Azrieli CHU Ste-Justine Research Center, Montreal, QC, Canada.
Keshav GoëlDepartment of Neurosurgery, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA, United States.
Catherine KormanBrain and Development Research Axis, Azrieli CHU Ste-Justine Research Center, Montreal, QC, Canada.
Tiphaine PorteUnité de Recherche Clinique Appliquée, Sainte-Justine Hospital, Université de Montréal, Montreal, QC, Canada.
Thierry DucruetUnité de Recherche Clinique Appliquée, Sainte-Justine Hospital, Université de Montréal, Montreal, QC, Canada.
Giulia CossuDepartment of Neuroscience, Section of Neurosurgery, University Hospital of Lausanne and University of Lausanne, Lausanne, Switzerland.
Christina BriscoeDivision of Epilepsy and Clinical Neurophysiology, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, United States.
Avantika SinghDepartment of Neurology, Division of Pediatric Neurology, Children's Wisconsin, Medical College of Wisconsin, Milwaukee, WI, United States.
Chellamani HariniDivision of Epilepsy and Clinical Neurophysiology, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, United States.
George M IbrahimNeuroscience and Mental Health, The Hospital for Sick Children, Toronto, ON, Canada.
Aria FallahDepartment of Neurosurgery, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA, United States.
Alexander G WeilBrain and Development Research Axis, Azrieli CHU Ste-Justine Research Center, Montreal, QC, Canada.
Aristides HadjinicolaouBrain and Development Research Axis, Azrieli CHU Ste-Justine Research Center, Montreal, QC, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epileptic spasms (ES) are a unique seizure type typically presenting in the form of infantile epileptic spasms syndrome (IESS) with characteristic hypsarrhythmia on scalp EEG and a preponderance with developmental delay or regression. While pharmacotherapy is the mainstay of treatment, surgical options, including disconnective or resective procedures, are increasingly recognized as viable therapeutic options for recurrent or persistent ES. However, limited data on safety, effectiveness, and prognostic factors hinder informed decision-making regarding surgery indications, timing, and intervention type. We performed a systematic review and an individual patient data meta-analysis (IPDMA) in accordance with PRISMA guidelines, focusing on surgical interventions for ES and reporting seizure outcomes using the Engel or ILAE scales. Twenty-six studies encompassing 358 ES patients undergoing resection/callosotomy were included. Participants undergoing other approaches (e.g., multiple subpial transections) or multimodality approaches were excluded from analysis. The median age at spasm onset was 6 months (IQR = 3.0-15.6), with a median age at surgery of 37 months (IQR = 17.2-76.8). Most patients (74.1%) exhibited additional seizure types. A total of 136 patients (35.8%) underwent corpus callosotomy (CC), of whom 125 (91.9%) had a complete callosotomy, while 11 (8.1%) had a partial callosotomy. Resective surgery was performed on 222 patients (58.4%). Among those who underwent resection, 109 (49.1%) had both lesional MRI findings and lateralized EEG abnormalities. Overall, 201 patients (56.1%) remained spasm-free at a median postoperative follow-up of 36 months (interquartile range, IQR = 21-60), including 52 (38.2%) from the callosotomy group and 149 (67.1%) from the resective surgery group. In the resective surgery cohort, patients with MRI-confirmed lesions (

Indexed as

corpus callosotomyepileptic spasmshemisperhrectomyresective surgeryseizure outcomes

Identifiers

PMID39807246
PMCPMC11726465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.